FAM19A5 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62436730732907E-12 |
Normal-vs-Stage2 |
3.68520000071371E-08 |
Normal-vs-Stage3 |
2.54463117244086E-13 |
Normal-vs-Stage4 |
2.47439846390307E-11 |
Stage1-vs-Stage2 |
4.061600E-02 |
Stage1-vs-Stage3 |
4.720200E-01 |
Stage1-vs-Stage4 |
2.830200E-01 |
Stage2-vs-Stage3 |
2.312200E-02 |
Stage2-vs-Stage4 |
1.473910E-02 |
Stage3-vs-Stage4 |
7.762600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
2.593700E-04 |
Normal-vs-Asian |
9.96050020241057E-10 |
Caucasian-vs-AfricanAmerican |
8.596400E-01 |
Caucasian-vs-Asian |
8.210200E-01 |
AfricanAmerican-vs-Asian |
7.537800E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
2.600800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
1.26565424807268E-14 |
Normal-vs-Age(81-100Yrs) |
7.770000E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.965000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.273800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.855600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.426200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.038600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.408600E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
3.824300E-02 |
Classical-VS-Follicular |
7.887900E-02 |
Classical-VS-Other |
5.514200E-01 |
Classical-VS-Normal |
<1E-12 |
Tall-VS-Follicular |
3.923500E-03 |
Tall-VS-Other |
8.792200E-01 |
Tall-VS-Normal |
6.9182000017598E-08 |
Follicular-VS-Other |
9.397800E-02 |
Follicular-VS-Normal |
2.20323759236862E-12 |
Other-VS-Normal |
1.554160E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
1.58379975800926E-11 |
N0-vs-N1 |
6.108000E-01 |
|
|